Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AI hunts new uses for Phase 3 metabolic drug
12+ hour, 12+ min ago (523+ words) longevity.technology AI hunts new uses for Phase 3 metabolic drug Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: THPharm already has…...
AI sharpens Alzheimer’s PET readouts
4+ mon, 2+ week ago (775+ words) Alzheimer’s PET scans have been able to show the biological hallmarks of disease for years – sticky amyloid plaques and tau tangles, but there’s been a frustrating catch. Seeing those signals on a scan does not always neatly explain what a…...
Partnership brings new AI model promising faster drug discovery
5+ mon, 3+ week ago (649+ words) Discovering new medicines doesn’t have to take years of trial and error. Promising compounds aren’t lost in a mountain of experiments, and patient breakthroughs happen faster. That’s the vision behind the new partnership between Insilico Medicine and Liquid AI, two…...
LillyPod is now live to power faster, smarter drug discovery
5+ mon, 4+ week ago (622+ words) This week, pharma giant Eli Lilly and AI computing leader NVIDIA quietly flipped a switch that could redefine the future of medicine. Meet LillyPod, the most powerful AI supercomputer owned and operated by a pharmaceutical company, officially inaugurated during a…...
Scienta’s new AI model targets aging-linked inflammation
6+ mon, 1+ week ago (581+ words) Julien Duquesne, CTO and co-founder of Scienta Lab, explains that “the goal is not to replace experimentation, but to better guide decision-making at every stage of the development.” In other words, EVA isn’t a replacement for scientists, but a co-pilot…...
Proxima lands $80m to make protein interactions programmable
7+ mon, 2+ week ago (551+ words) AI-native biotech Proxima has raised $80 million in an oversubscribed seed round to advance new medicines designed to control how proteins interact with one another. Previously known as VantAI, the company has rebranded as Proxima to reflect its focus on “proximity…...